FDA — authorised 24 November 2015
- Marketing authorisation holder: ELI LILLY CO
- Status: approved
🇺🇸 Portrazza in United States
FDA authorised Portrazza on 24 November 2015
Marketing authorisations
FDA — authorised 24 November 2015
- Application: BLA125547
- Marketing authorisation holder: ELI LILLY CO
- Local brand name: PORTRAZZA
- Indication: INJECTABLE — INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
- Status: approved
Portrazza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Portrazza approved in United States?
Yes. FDA authorised it on 24 November 2015; FDA authorised it on 24 November 2015.
Who is the marketing authorisation holder for Portrazza in United States?
ELI LILLY CO holds the US marketing authorisation.